March 4, 2015—Patients receiving care in hospital outpatient departments are sicker and poorer than those receiving care in physician offices and could lose access to care if Congress significantly reduces payments to outpatient departments, a new study has found. … [Read more...]
House Appropriations Chairman Questions 340B User Fee
Levy will "wreak havoc" in rural areas, Rep. Rogers saysMarch 4, 2015—The Obama administration's proposed 0.1 percent user fee on 340B drug purchases "will wreak havoc on healthcare providers, especially those in rural areas," the chairman of the House Appropriations Committee has told the Secretary of Health and Human Services. … [Read more...]
PhRMA Says HRSA Misinterprets 340B Orphan Drug Exclusion
Asks court to declare interpretive rule invalidFebruary 26, 2015—The Department of Health and Human Services Health Resources and Services Administration cannot second-guess Congress and rewrite the 340B orphan drug exclusion "to make the statute correspond with the agency's policy preference," brand-name drugmakers said yesterday in a court filing. … [Read more...]
House Subcommittee Holding 340B Hearing Next Week
Will hear from government witnesses on March 5February 25, 2015—The House Energy & Commerce Health Subcommittee has scheduled a hearing on the 340B program for March 5 at 10:00 a.m. … [Read more...]
Record Breaking 49 Orphan Drugs Approved in 2014
New filing by PhRMA in 340B lawsuit is due by Feb. 25February 19, 2015—In another sign of orphan drugs' rising prominence in drugmakers' portfolios, an industry blog reports that the Food and Drug Administration approved 53 percent more orphan products in 2014 than in 2013. … [Read more...]
More Details Emerge on 340B Audit of Drug Manufacturer
Fairness of allocation procedures also being examinedFebruary 12, 2015—More information about the first 340B program audit of a drug manufacturer emerged today during a drug industry government pricing conference in Washington. … [Read more...]
Hospitals Back HHS in 340B Orphan Drug Lawsuit
Groups file briefs defending HRSA's interpretive ruleFebruary 11, 2015—Hospital groups have asked a federal district judge to dismiss the drug industry's lawsuit challenging the 340B orphan drug exclusion interpretive rule. … [Read more...]